Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ May 06, 2021
Dry powder inhaler formulation of Cu,Zn-superoxide dismutase by spray drying: A proof-of-concept
Read more
Scientific Article
/ Sep 25, 2021
Dry powder inhaler formulation comparison: Study of the role of particle deposition pattern and dissolution
Read more
Scientific Article
Scientific Article